전남대학교 중앙도서관

A systematic analysis of the human immune response to Plasmodium vivax.

학술저널

issue: The Journal of clinical investigation [J Clin Invest] 2023 Oct 16; Vol. 133 (20). Date of Electronic Publication: 2023 Oct 16.
Author: Bach FA; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom.
Muñoz Sandoval D; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom.; Insitute of Microbiology, Universidad San Francisco de Quito, Quito, Ecuador.
Mazurczyk M; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, and.
Themistocleous Y; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Rawlinson TA; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Harding AC; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom.
Kemp A; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
Silk SE; The Jenner Institute, University of Oxford, Oxford, United Kingdom.; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.
Barrett JR; The Jenner Institute, University of Oxford, Oxford, United Kingdom.; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.
Edwards NJ; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Ivens A; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom.
Rayner JC; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
Minassian AM; The Jenner Institute, University of Oxford, Oxford, United Kingdom.; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.
Napolitani G; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, and.
Draper SJ; The Jenner Institute, University of Oxford, Oxford, United Kingdom.; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.
Spence PJ; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom.
DB Label: Database : MEDLINE

원문보기: Open Access (PubMed Central) 등재 - Web of Science (SCIE) 조회 - Impact Factor (JCR)

Broadly neutralizing aptamers to SARS-CoV-2: A diverse panel of modified DNA antiviral agents.

학술저널

issue: Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2023 Mar 14; Vol. 31, pp. 370-382. Date of Electronic Publication: 2023 Jan 21.
Author: Gelinas AD; SomaLogic, Inc., 2945 Wilderness Place, Boulder, CO 80301, USA.
Tan TK; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK.
Liu S; James & Lillian Martin Centre, Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK.
Jaramillo JG; James & Lillian Martin Centre, Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK.
Chadwick J; James & Lillian Martin Centre, Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK.
Harding AC; James & Lillian Martin Centre, Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK.
Zhang C; SomaLogic, Inc., 2945 Wilderness Place, Boulder, CO 80301, USA.
Ream BE; SomaLogic, Inc., 2945 Wilderness Place, Boulder, CO 80301, USA.
Chase CN; SomaLogic, Inc., 2945 Wilderness Place, Boulder, CO 80301, USA.
Otis MR; SomaLogic, Inc., 2945 Wilderness Place, Boulder, CO 80301, USA.
Lee T; Department of Biochemistry, University of Colorado, Boulder, JSCBB, C1B90, 3415 Colorado Avenue, Boulder, CO 80303, USA.
Schneider DJ; SomaLogic, Inc., 2945 Wilderness Place, Boulder, CO 80301, USA.
James WS; James & Lillian Martin Centre, Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK.
Janjic N; SomaLogic, Inc., 2945 Wilderness Place, Boulder, CO 80301, USA.
DB Label: Database : MEDLINE

원문보기: Open Access (PubMed Central) Full Text (ScienceDirect O/A) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern.

학술저널

issue: Communications medicine [Commun Med (Lond)] 2022 Apr 05; Vol. 2, pp. 36. Date of Electronic Publication: 2022 Apr 05 (Print Publication: 2022).
Author: Ertesvåg NU; Influenza Centre, University of Bergen, Bergen, Norway.
Xiao J; MRC Human Immunology Unit, MRC Weatherall Institute, John Radcliffe Hospital, Oxford, UK.
Zhou F; Influenza Centre, University of Bergen, Bergen, Norway.
Ljostveit S; Influenza Centre, University of Bergen, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway.
Sandnes H; Department of Clinical Science, University of Bergen, Bergen, Norway.
Lartey S; Influenza Centre, University of Bergen, Bergen, Norway.; Department of Microbiology, Haukeland University Hospital, Bergen, Norway.
Sævik M; Department of Medicine, Haukeland University Hospital, Bergen, Norway.
Hansen L; Influenza Centre, University of Bergen, Bergen, Norway.
Madsen A; Influenza Centre, University of Bergen, Bergen, Norway.; Department of Microbiology, Haukeland University Hospital, Bergen, Norway.
Mohn KGI; Influenza Centre, University of Bergen, Bergen, Norway.; Department of Medicine, Haukeland University Hospital, Bergen, Norway.
Fjelltveit E; Influenza Centre, University of Bergen, Bergen, Norway.; Department of Microbiology, Haukeland University Hospital, Bergen, Norway.
Olofsson JS; Influenza Centre, University of Bergen, Bergen, Norway.
Tan TK; MRC Human Immunology Unit, MRC Weatherall Institute, John Radcliffe Hospital, Oxford, UK.
Rijal P; MRC Human Immunology Unit, MRC Weatherall Institute, John Radcliffe Hospital, Oxford, UK.
Schimanski L; MRC Human Immunology Unit, MRC Weatherall Institute, John Radcliffe Hospital, Oxford, UK.
Øyen S; Eidsvåg Family Practice, Bergen, Norway.
Brokstad KA; Broegelmann Research Laboratory, University of Bergen, Bergen, Norway.; Department of Safety, Chemistry and Biomedical Laboratory Sciences, Western Norway University of Applied Sciences, Bergen, Norway.
Dunachie S; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Jämsén A; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
James WS; Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, OX1 3RE UK.
Harding AC; Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, OX1 3RE UK.
Harvala H; Microbiology Services, NHS Blood and Transplant, Colindale, UK.
Nguyen D; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.
Roberts D; Clinical, Research and Development, NHS Blood and Transplant, Oxford, UK.
Zambon M; Virology Reference Department, National Infection Service, Public Health England, Colindale, UK.
Townsend A; MRC Human Immunology Unit, MRC Weatherall Institute, John Radcliffe Hospital, Oxford, UK.
Langeland N; Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Medicine, Haukeland University Hospital, Bergen, Norway.; National Advisory Unit for Tropical Infectious Diseases, Haukeland University Hospital, Bergen, Norway.
Cox RJ; Influenza Centre, University of Bergen, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Microbiology, Haukeland University Hospital, Bergen, Norway.
DB Label: Database : MEDLINE

원문보기: OA (Springer) Open Access (PubMed Central) OA (Nature)

Divergent trajectories of antiviral memory after SARS-CoV-2 infection.

학술저널

issue: Nature communications [Nat Commun] 2022 Mar 10; Vol. 13 (1), pp. 1251. Date of Electronic Publication: 2022 Mar 10.
Author: Tomic A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. info@adrianatomic.com.
Skelly DT; Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Nuffield Dept of Clinical Neuroscience, University of Oxford, Oxford, UK.
Ogbe A; Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.
O'Connor D; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Pace M; Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.
Adland E; Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.
Alexander F; United Kingdom Health Security Agency, Porton Down, Wiltshire, England.
Ali M; Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.
Allott K; Department of Clinical Biochemistry, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Azim Ansari M; Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.
Belij-Rammerstorfer S; Jenner Institute, University of Oxford, Oxford, UK.
Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Blackwell L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Brown A; Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.
Brown H; Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.
Cavell B; United Kingdom Health Security Agency, Porton Down, Wiltshire, England.
Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
de Silva T; The Florey Institute for Host-Pathogen Interactions and Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, UK.
Eyre D; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Big Data Institute, Nuffield Dept. of Population Health, University of Oxford, Oxford, UK.
Lumley S; Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Flaxman A; Jenner Institute, University of Oxford, Oxford, UK.
Grist J; Department of Physiology, Anatomy, and Genetics, University of Oxford, Oxford, UK.
Hackstein CP; Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.
Halkerston R; United Kingdom Health Security Agency, Porton Down, Wiltshire, England.
Harding AC; James & Lillian Martin Centre, Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
Hill J; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.
James T; Department of Clinical Biochemistry, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Jay C; Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.
Johnson SA; Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Oxford University Medical School, Medical Sciences Division, University of Oxford, Oxford, UK.
Kronsteiner B; Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.; Oxford Centre For Global Health Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.
Lie Y; Monogram Biosciences LabCorp, San Francisco, CA, USA.
Linder A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Longet S; United Kingdom Health Security Agency, Porton Down, Wiltshire, England.; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Marinou S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Matthews PC; Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Mellors J; United Kingdom Health Security Agency, Porton Down, Wiltshire, England.
Petropoulos C; Monogram Biosciences LabCorp, San Francisco, CA, USA.
Rongkard P; Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.; Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.
Sedik C; Monogram Biosciences LabCorp, San Francisco, CA, USA.
Silva-Reyes L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Smith H; Jenner Institute, University of Oxford, Oxford, UK.
Stockdale L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Taylor S; United Kingdom Health Security Agency, Porton Down, Wiltshire, England.
Thomas S; United Kingdom Health Security Agency, Porton Down, Wiltshire, England.
Tipoe T; Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.
Turtle L; HPRU in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.; Tropical and Infectious Disease Unit, Liverpool University Hospitals NHS Foundation Trust (a member of Liverpool Health Partners), Liverpool, UK.
Vieira VA; Peter Medawar Building for Pathogen Research, Department of Paediatrics, University of Oxford, Oxford, UK.
Wrin T; Monogram Biosciences LabCorp, San Francisco, CA, USA.
Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Lambe T; Jenner Institute, University of Oxford, Oxford, UK.
Conlon CP; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Jeffery K; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Travis S; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Goulder P; Peter Medawar Building for Pathogen Research, Department of Paediatrics, University of Oxford, Oxford, UK.
Frater J; Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Mentzer AJ; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Stafford L; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Carroll MW; United Kingdom Health Security Agency, Porton Down, Wiltshire, England.; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
James WS; James & Lillian Martin Centre, Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
Klenerman P; Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Barnes E; Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK. ellie.barnes@ndm.ox.ac.uk.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK. ellie.barnes@ndm.ox.ac.uk.; NIHR Oxford Biomedical Research Centre, Oxford, UK. ellie.barnes@ndm.ox.ac.uk.; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK. ellie.barnes@ndm.ox.ac.uk.
Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Dunachie SJ; Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Oxford Centre For Global Health Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.; Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.
DB Label: Database : MEDLINE

원문보기: OA (Springer) Open Access (PubMed Central) OA (Nature) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern.

학술저널

issue: Nature communications [Nat Commun] 2021 Aug 17; Vol. 12 (1), pp. 5061. Date of Electronic Publication: 2021 Aug 17.
Author: Skelly DT; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Nuffield Department of Clinial Neurosciences, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Harding AC; James and Lillian Martin Centre, Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
Gilbert-Jaramillo J; James and Lillian Martin Centre, Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
Knight ML; James and Lillian Martin Centre, Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
Longet S; Public Health England, Porton Down, UK.; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Brown A; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Adele S; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Adland E; Peter Medawar Building for Pathogen Research, Department of Paediatrics, University of Oxford, Oxford, UK.
Brown H; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Tipton T; Public Health England, Porton Down, UK.; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Stafford L; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Mentzer AJ; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Johnson SA; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Medical Sciences Division, University of Oxford, Oxford, UK.
Amini A; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Tan TK; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Schimanski L; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Centre for Translational Immunology, Chinese Academy of Medical Sciences, Oxford Institute, University of Oxford, Oxford, UK.
Huang KA; Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, and Taipei Medical University, Taipei, Taiwan.
Rijal P; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Centre for Translational Immunology, Chinese Academy of Medical Sciences, Oxford Institute, University of Oxford, Oxford, UK.
Frater J; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Goulder P; Peter Medawar Building for Pathogen Research, Department of Paediatrics, University of Oxford, Oxford, UK.
Conlon CP; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Jeffery K; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Sigal A; Africa Health Research Institute, Durban, South Africa.; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, 4001, South Africa.; Max Planck Institute for Infection Biology, Berlin, Germany.
de Oliveira T; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, 4001, South Africa.; KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.; Department of Global Health, University of Washington, Seattle, WA, USA.
Townsend AR; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Centre for Translational Immunology, Chinese Academy of Medical Sciences, Oxford Institute, University of Oxford, Oxford, UK.
Klenerman P; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Dunachie SJ; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Mahidol-Oxford Tropical Medicine Research Unit, Bangkok, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Barnes E; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Carroll MW; Public Health England, Porton Down, UK.; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
James WS; James and Lillian Martin Centre, Sir William Dunn School of Pathology, University of Oxford, Oxford, UK. william.james@path.ox.ac.uk.
DB Label: Database : MEDLINE

원문보기: OA (Springer) Open Access (PubMed Central) OA (Nature) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells.

학술저널

issue: Cell reports [Cell Rep] 2021 Apr 20; Vol. 35 (3), pp. 109020. Date of Electronic Publication: 2021 Apr 05.
Author: Wing PAC; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Chinese Academy of Medical Sciences (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.
Keeley TP; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK.
Zhuang X; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Lee JY; Department of Biochemistry, University of Oxford, Oxford, UK.
Prange-Barczynska M; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK.
Tsukuda S; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Morgan SB; Respiratory Medicine Unit and National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), Nuffield Department of Medicine, Experimental Medicine, University of Oxford, Oxford, UK.
Harding AC; Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.
Argles ILA; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Kurlekar S; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Noerenberg M; Department of Biochemistry, University of Oxford, Oxford, UK; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Thompson CP; Peter Medawar Building for Pathogen Research, Department of Zoology, University of Oxford, Oxford, UK.
Huang KA; Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan, Taiwan; Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Balfe P; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Watashi K; Department of Virology II, National Institute of Infectious Diseases, Tokyo 162-8640, Japan; Department of Applied Biological Science, Tokyo University of Science, Noda 278-8510, Japan.
Castello A; Department of Biochemistry, University of Oxford, Oxford, UK; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Hinks TSC; Respiratory Medicine Unit and National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), Nuffield Department of Medicine, Experimental Medicine, University of Oxford, Oxford, UK.
James W; Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.
Ratcliffe PJ; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK; Francis Crick Institute, London, UK.
Davis I; Department of Biochemistry, University of Oxford, Oxford, UK.
Hodson EJ; Francis Crick Institute, London, UK; Department of Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, UK.
Bishop T; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK.
McKeating JA; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Chinese Academy of Medical Sciences (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK. Electronic address: jane.mckeating@ndm.ox.ac.uk.
DB Label: Database : MEDLINE

원문보기: Full Text (ScienceDirect O/A) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

Efficacy of a bio-electric dressing in healing deep, partial-thickness wounds using a porcine model .

학술저널

issue: Ostomy/wound management [Ostomy Wound Manage] 2012 Sep; Vol. 58 (9), pp. 50-5.
Author: Harding AC; University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Gil J
Valdes J
Solis M
Davis SC
DB Label: Database : MEDLINE

원문보기

In "Step" with HIV Vaccines? A Content Analysis of Local Recruitment Campaigns for an International HIV Vaccine Study.

학술저널

issue: Journal of health & mass communication [J Health Mass Commun] 2009; Vol. 1 (1), pp. 11-39.
Author: Frew PM; Assistant professor of Medicine (Infectious Diseases) and Behavioral Sciences and Health Education at Emory University ( pfrew@emory.edu ).
Macias W
Chan K
Harding AC
DB Label: Database : MEDLINE

원문보기

바구니보기

링크메뉴

주메뉴

전자자료 상세검색

전자자료 상세검색

전체선택